Venture Capital Still Has Place In Biotech Financing
Executive Summary
SAN FRANCISCO-Despite biotech's increasing leverage in partnerships with big pharma, venture capital financing may still be the best way for biotech companies to maintain development control of early-stage products, several members of an industry panel said at the recent BIO Investor Forum